Centene (CNC) Competitors $28.82 +0.17 (+0.58%) Closing price 08/27/2025 03:59 PM EasternExtended Trading$28.96 +0.13 (+0.45%) As of 07:47 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNC vs. ELV, MOH, SEM, HUM, UNH, CI, JYNT, AEMD, COR, and BDXShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Humana (HUM), UnitedHealth Group (UNH), Cigna Group (CI), Joint (JYNT), Aethlon Medical (AEMD), Cencora (COR), and Becton, Dickinson and Company (BDX). These companies are all part of the "medical" sector. Centene vs. Its Competitors Elevance Health Molina Healthcare Select Medical Humana UnitedHealth Group Cigna Group Joint Aethlon Medical Cencora Becton, Dickinson and Company Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment. Do analysts recommend CNC or ELV? Centene presently has a consensus price target of $42.20, indicating a potential upside of 46.40%. Elevance Health has a consensus price target of $413.81, indicating a potential upside of 33.68%. Given Centene's higher possible upside, equities analysts plainly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 1 Sell rating(s) 13 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.12Elevance Health 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has higher earnings and valuation, CNC or ELV? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$163.07B0.09$3.31B$4.047.13Elevance Health$177.01B0.39$5.98B$23.5013.17 Which has more volatility and risk, CNC or ELV? Centene has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Is CNC or ELV more profitable? Elevance Health has a net margin of 2.83% compared to Centene's net margin of 1.15%. Elevance Health's return on equity of 17.59% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene1.15% 9.57% 3.10% Elevance Health 2.83%17.59%6.36% Do institutionals and insiders have more ownership in CNC or ELV? 93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.4% of Centene shares are owned by insiders. Comparatively, 0.3% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer CNC or ELV? In the previous week, Centene had 28 more articles in the media than Elevance Health. MarketBeat recorded 62 mentions for Centene and 34 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.48 beat Centene's score of 0.48 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 19 Very Positive mention(s) 1 Positive mention(s) 37 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Elevance Health 30 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryElevance Health beats Centene on 12 of the 16 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneMED IndustryMedical SectorNYSE ExchangeMarket Cap$14.08B$41.35B$5.79B$21.25BDividend YieldN/A68.84%3.95%3.53%P/E Ratio7.1310.0630.8329.20Price / Sales0.091.55462.9153.35Price / Cash2.908.7337.7623.64Price / Book0.512.2910.105.36Net Income$3.31B$2.64B$3.26B$996.59M7 Day Performance0.01%-2.40%2.77%2.99%1 Month Performance7.28%7.12%3.94%2.88%1 Year Performance-63.13%-34.86%43.03%12.54% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.8714 of 5 stars$28.83+0.6%$42.20+46.4%-63.0%$14.08B$163.07B7.1360,500Trending NewsAnalyst ForecastELVElevance Health4.89 of 5 stars$310.03+0.1%$413.81+33.5%-43.6%$69.81B$177.01B13.19104,200Positive NewsMOHMolina Healthcare4.9428 of 5 stars$169.48+1.2%$242.91+43.3%-49.7%$9.19B$43.41B8.3518,000Positive NewsAnalyst ForecastSEMSelect Medical4.9978 of 5 stars$12.92+1.6%$24.60+90.4%-63.1%$1.60B$5.19B12.1944,100Positive NewsHUMHumana4.1895 of 5 stars$287.75+0.5%$281.43-2.2%-15.9%$34.61B$117.76B22.0865,680Positive NewsDividend AnnouncementUNHUnitedHealth Group4.9457 of 5 stars$308.84+1.6%$367.71+19.1%-48.3%$279.71B$422.82B13.38400,000Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading VolumeCICigna Group4.9978 of 5 stars$298.88+0.7%$378.33+26.6%-15.2%$79.78B$247.12B16.3173,500Positive NewsAnalyst ForecastJYNTJoint4.0432 of 5 stars$10.55-3.1%$16.33+54.8%-4.7%$161.84M$51.90M-31.97320Positive NewsHigh Trading VolumeAEMDAethlon Medical2.5138 of 5 stars$1.17+2.6%$56.00+4,686.3%-58.2%$3.04MN/A-0.0910CORCencora4.5059 of 5 stars$290.45-0.8%$311.25+7.2%+24.5%$56.31B$293.96B29.8846,000Positive NewsBDXBecton, Dickinson and Company4.26 of 5 stars$195.22-0.4%$211.44+8.3%-17.8%$55.96B$20.18B35.1174,000Positive News Related Companies and Tools Related Companies ELV Alternatives MOH Alternatives SEM Alternatives HUM Alternatives UNH Alternatives CI Alternatives JYNT Alternatives AEMD Alternatives COR Alternatives BDX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNC) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access